ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,113.73
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Molecular Insight Pharmaceuticals (MM) (MIPI)

  7. Molecular Insight Pharmaceuticals (MM) (MIPI) News

Molecular Insight Pharmaceuticals (MM) (MIPI)

Molecular Insight Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MIPI
DateTimeSourceHeadlineSymbolCompany
21/12/201000:42MarketwiredMolecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB(TM) MarketplaceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/12/201016:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/12/201021:39Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
10/12/201003:46MarketwiredMolecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management ChangesNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201011:02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201000:38MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/11/201022:16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/11/201021:59MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201017:43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201014:31Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201012:21MarketwiredMolecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational ResultsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/11/201021:28Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/11/201021:18MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/10/201022:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/10/201021:49MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201021:51Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201021:30MarketwiredMolecular Insight Pharmaceuticals Data Indicate Trofex(TM) May Enable Visualization and Monitoring of Response to Prostate CanceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201021:01MarketwiredMolecular Insight Announces Resignation of Chief Medical OfficerNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
15/10/201022:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
15/10/201022:13MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/10/201021:49MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for DetecNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/10/201013:00MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LettersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201017:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201016:47MarketwiredMolecular Insight Receives Eleventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201019:58Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201019:51Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201016:16MarketwiredMolecular Insight Receives Tenth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201015:04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201013:00MarketwiredMolecular Insight Receives Ninth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/09/201020:38Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:MIPI

Your Recent History

LSE
VAST
Vast Resources
LSE
IQE
Iqe
LSE
LLOY
Lloyds Banking
LSE
BOO
Boohoo
LSE
ZED
Zenova
LSE
RKH
Rockhopper Exploration
LSE
NG.
National Grid
LSE
BARC
Barclays
LSE
HUM
Hummingbird Resources
LSE
ITM
Itm Power
LSE
THUS
Thus
LSE
GDR
Genedrive
LSE
VRS
Versarien
LSE
POS
Plexus
LSE
WG.
Wood Group (john)
LSE
CUSN
Cornish Metals
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved